Day One Biopharmaceuticals, Inc. earnings per share and revenue

DAWN earnings per share for the last quarter are -0.63 USD whereas the estimation was -0.36 USD which accounts for -73.81% surprise. Company revenue for the same period amounts to 29.20 M USD despite the estimated figure of 27.83 M USD. Estimated earnings per share for the next quarter are -0.45 USD, and revenue is expected to reach 31.47 M USD. Also watch annual changes over time to get a bigger picture of DAWN earnings per share and revenue dynamics.